REG - Aquis Exchange PLC - Admission to Trading on the AQSE Growth Market

Aquis ExchangeAnnouncement

29/03/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220329:nRSc3053Ga&default-theme=true

RNS Number : 3053G  Aquis Exchange PLC  29 March 2022

29 March 2022

Aquis Exchange PLC

("Aquis" or the "Group")

Admission to trading on the Aquis Stock Exchange Growth Market

Aquis Exchange PLC (AQX.L), the exchange services group, is pleased to
announce that further to its announcement of 11 March 2022, it has completed
its dual listing on the Aquis Stock Exchange ("AQSE"). Therefore, its entire
issued share capital has today been admitted to the Apex segment of the AQSE
under its existing ISIN "GB00BD5JNK30". The Group's shares will continue to
trade on AIM.

 

Alasdair Haynes, CEO of Aquis Exchange PLC said:

 

"Today marks a historic day for the Group as we begin trading on our very own
Growth Market. Through our hard work over the past two years, AQSE has become
a serious challenger stock exchange and we look forward to seeing it become
home to many more growth companies like ourselves in the years to come."

 

Enquiries:

Aquis Exchange PLC via

 Alma PR (Financial PR Adviser):                               Tel: +44 (0)20 3405 0209

 Susie Hudson                                                   aquis@almapr.co.uk

 Kieran Breheny

 VSA Capital Limited (AQSE Corporate Adviser)                  Tel: +44(0)20 3005 5000

 Andrew Raca

 Pascal Wiese

 Liberum Capital Limited (Nominated Adviser and Joint Broker)  Tel: +44 (0) 20 3100 2000

 Chris Clarke

 Clayton Bush

 Edward Thomas

 Kane Collings

 Canaccord Genuity Limited (Joint Broker)                      Tel: +44 (0) 20 7523 8000

 Bobbie Hilliam

 Patrick Dolaghan

 

Notes to Editors

About Aquis Exchange PLC

Aquis Exchange PLC is an exchange services group, which operates pan-European
cash equities trading businesses (Aquis Exchange), growth and regulated
primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange
software to third parties (Aquis Technologies).

Aquis Exchange is authorised and regulated by the UK Financial Conduct
Authority and France's Autorité des Marchés Financiers to operate
Multilateral Trading Facility businesses in the UK/Switzerland and in EU27
respectively. Aquis operates lit order books and does not allow aggressive
non-client proprietary trading, which has resulted in lower market impact and
signalling risk on Aquis than other trading venues in Europe. According to
independent studies, trades on Aquis are less likely to lead to price movement
than on other lit markets. Aquis uses a subscription pricing model which works
by charging users according to the message traffic they generate, rather than
a percentage of the value of each stock that they trade.

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary
markets for equity and debt products. It is authorised as a Recognised
Investment Exchange, which allows it to operate a regulated listings venue.
The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with
different levels of admission criteria. The Access market focuses on earlier
stage growth companies, while Apex is the intended market for larger, more
established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange
PLC. It creates and licenses cutting-edge, cost-effective matching engine and
trade surveillance technology for banks, brokers, investment firms and
exchanges.

Aquis Exchange PLC (AQX.L) is listed on the AIM Market of the London Stock
Exchange plc. For more information, please go to www.aquis.eu.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFFDVTITFIF